Search Login Register

Perivascular Epithelioid Cell Neoplasms Summary

Description: A family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. These cells do not have a normal anatomic homolog. (From Fletcher CDM, et. al., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, 2002).

Also Known As: CCMMT; Neoplasms, Perivascular Epithelioid Cell; Perivascular Epithelioid Cell Tumors; Clear Cell Myomelanocytic Tumors; Clear Cell Sugar Tumors Show All >>

Networked: 113 relevant articles (2 outcomes, 8 trials/studies) for this Disease

Key Drugs and Agents for Perivascular Epithelioid Cell Neoplasms

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Sirolimus (Rapamycin) : 1 outcome 1 study in 13 results : FDA 2
  2. Glycoproteins (Glycoprotein) : 1 outcome 1 study in 2 results : IBA
  3. Cathepsin K : 4 studies in 6 results : IBA
  4. Microphthalmia-Associated Transcription Factor : 2 studies in 3 results : IBA
  5. MART-1 Antigen : 1 study in 14 results : IBA
  6. Carbon Monoxide : 1 study in 10 results : IBA
  7. temsirolimus : 1 study in 5 results : FDA 1
  8. Adenocarcinoma of lung : 1 study in 2 results : IBA
  9. Streptavidin : 1 study in 1 result : IBA
  10. Polymers : 1 study in 1 result : IBA
Show All >>

Diseases Related to Perivascular Epithelioid Cell Neoplasms

  1. Neoplasms (Cancer)
  2. Perivascular Epithelioid Cell Neoplasms
  3. Lymphangioleiomyomatosis (Lymphangiomyomatosis)
  4. Renal Cell Carcinoma (Grawitz Tumor)
  5. Alveolar Soft Part Sarcoma
Show All >>

Key Therapies for Perivascular Epithelioid Cell Neoplasms

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 6 results
  2. Hysterectomy : 3 results
  3. Cystectomy : 2 results
  4. Radiotherapy : 2 results
  5. Nephrectomy : 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.